Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2019-04-30 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Certificate under Regulation 54(5) of SEBI (Depositories and Participants), Regulations 1996 for the quarter ended March 2019 ('Period'). Attached is the letter from our R&T agent - Link ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 54(5) of SEBI (Depositories and Participants) Regulations, 1996, certifying the dematerialization of shares for the quarter ended March 2019. It includes detailed tables of share quantities dematerialized and references to letters from the Registrar and Transfer Agent. The document is a compliance certificate related to share dematerialization and does not contain financial statements, management discussion, or earnings data. It is not an annual or interim report, nor an earnings release or investor presentation. It is a regulatory compliance certificate filed with stock exchanges and depositories. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2019-04-30 English
Certificate under Regulation 54(5) of SEBI (Depositories and Participants), Regulations 1996 for the quarter ended March 2019 ('Period'). Attached is the letter from our R&T agent - Link ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 54(5) of SEBI (Depositories and Participants) Regulations, 1996, certifying the dematerialization of shares for the quarter ended March 2019. It includes detailed tables of share quantities dematerialized and confirms that share certificates have been mutilated/cancelled and replaced by NSDL/CDSL ownership. The document is a compliance certificate related to share dematerialization and does not contain financial statements, management discussion, or other report content. It is a regulatory compliance certificate submitted to stock exchanges and depositories. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and not a financial report or announcement of a report.
2019-04-30 English
Please find enclosed herewith the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2019 received ....
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2019. It is a confirmation certificate from the Registrar and Transfer Agents regarding dematerialisation of securities and related compliance. The document is short (3515 characters) and serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report but a compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents that do not fit other specific categories.
2019-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to BSE Limited confirming the company's status in relation to SEBI circulars about 'Large Corporate' classification for the financial year 2019-20. It includes a declaration that DIL Limited is not a 'Large Corporate' as per the specified SEBI circulars. The document is dated April 30, 2019, and contains no financial statements or detailed financial data, only a compliance confirmation and declaration. It is a regulatory compliance communication rather than a financial report or announcement of financial results. The document length is short (2891 characters), and it does not contain or attach a full report but rather a declaration letter. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2019-04-30 English
Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated April 17, 2019 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the half year ended ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended March 31, 2019. It is a certificate from a company secretary confirming the timely issuance of share certificates related to transfers and transmissions during the specified period. The document is short (4226 characters) and primarily serves as a certification letter rather than a full financial or management report. It does not contain financial statements or detailed analysis but is a regulatory compliance certificate. According to the rules, such officer certifications or attestations should be classified as Regulatory Filings (RNS).
2019-04-25 English
As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It confirms that share transfer activities were maintained by the Registrar and Share Transfer Agent during a specified period. The document is a formal attestation or certification letter rather than a financial report or announcement of financial results. It does not contain financial statements or substantive financial data. It is also not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and attestation letters.
2019-04-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.